We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$39.7M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$34.3M
3
MRNA icon
Moderna
MRNA
+$29.3M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.3M
5
MTCH icon
Match Group
MTCH
+$9.52M

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$35.7M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
AAPL icon
Apple
AAPL
+$13.2M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.28M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$6.57M

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRE icon
1851
Costamare
CMRE
$1.74B
$287K ﹤0.01%
18,537
+8,118
+78% +$105K
MCHB
1852
Mechanics Bancorp
MCHB
$3.79B
$287K ﹤0.01%
6,963
-2,228
-24% -$87.1K
DMTK
1853
DELISTED
DermTech, Inc. Common Stock
DMTK
$284K ﹤0.01%
8,843
– –
AORT icon
1854
Artivion
AORT
$1.39B
$284K ﹤0.01%
12,730
– –
ATEN icon
1855
A10 Networks
ATEN
$1.96B
$284K ﹤0.01%
21,038
+8,729
+71% +$113K
VIVO
1856
DELISTED
Meridian Bioscience Inc
VIVO
$283K ﹤0.01%
14,711
-4,215
-22% -$84K
DHC
1857
Diversified Healthcare Trust
DHC
$2.03B
$283K ﹤0.01%
83,381
+19,441
+30% +$73.3K
SCSC icon
1858
Scansource
SCSC
$1.06B
$282K ﹤0.01%
8,101
– –
GSKY
1859
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$282K ﹤0.01%
25,198
+18,164
+258% +$143K
TVRD
1860
Tvardi Therapeutics
TVRD
$22.1M
$281K ﹤0.01%
506
– –
ACCO icon
1861
Acco Brands
ACCO
$399M
$281K ﹤0.01%
32,747
+11,113
+51% +$97.9K
SRCE icon
1862
1st Source
SRCE
$2.13B
$281K ﹤0.01%
5,951
-1,863
-24% -$84.8K
MITK icon
1863
Mitek Systems
MITK
$853M
$280K ﹤0.01%
15,147
– –
VNDA icon
1864
Vanda Pharmaceuticals
VNDA
$304M
$280K ﹤0.01%
16,331
-5,053
-24% -$88.5K
LGTY
1865
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$279K ﹤0.01%
11,730
– –
BRSP
1866
BrightSpire Capital
BRSP
$629M
$278K ﹤0.01%
29,648
+6,918
+30% +$66.9K
PLOW icon
1867
Douglas Dynamics
PLOW
$967M
$278K ﹤0.01%
7,665
-2,212
-22% -$85.3K
EGRX
1868
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$278K ﹤0.01%
4,988
– –
EFC
1869
Ellington Financial
EFC
$1.76B
$278K ﹤0.01%
15,211
– –
IDYA icon
1870
IDEAYA Biosciences
IDYA
$3.53B
$278K ﹤0.01%
10,897
– –
AVO icon
1871
Mission Produce
AVO
$1.15B
$278K ﹤0.01%
15,099
– –
PGC icon
1872
Peapack-Gladstone Financial
PGC
$822M
$277K ﹤0.01%
8,311
– –
ECOM
1873
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$277K ﹤0.01%
10,981
– –
COLL icon
1874
Collegium Pharmaceutical
COLL
$913M
$277K ﹤0.01%
14,032
– –
FMTX
1875
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$277K ﹤0.01%
11,944
– –
73 74
75
76 77

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.